Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)

ClinicalTrials.gov ID: NCT04494646

Public ClinicalTrials.gov record NCT04494646. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 7:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

BARCONA: A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)

Study identification

NCT ID
NCT04494646
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NYU Langone Health
Other
Enrollment
40 participants

Conditions and interventions

Conditions

Interventions

  • Bardoxolone Methyl Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 7, 2020
Primary completion
Jan 7, 2021
Completion
Jan 7, 2021
Last update posted
Jan 12, 2022

2020 – 2021

United States locations

U.S. sites
8
U.S. states
2
U.S. cities
5
Facility City State ZIP Site status
HSHS St. John's Hospital (Prairie Education and Research Cooperative) Springfield Illinois 62769
SIU School of Medicine Springfield Illinois 62794
NYU Langone Hospital - Brooklyn Brooklyn New York 11220
Coney Island Hospital Brooklyn New York 11235
Elmhurst Hospital Center Elmhurst New York 11373
NYU Winthrop Hospital Mineola New York 11501
NYU Bellevue Hospital Center New York New York 10016
NYU Langone Health New York New York 10016

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04494646, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2022 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04494646 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →